Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent

  • The PLOS ONE Staff

Notice of Republication

This article was republished on October 20, 2016, to correct an error in the title that was introduced during the typesetting process. The publisher apologizes for the errors. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected articles are provided here for reference.

Supporting Information

S1 File. Originally published, uncorrected article.

https://doi.org/10.1371/journal.pone.0170430.s001

(PDF)

S2 File. Republished, corrected article.

https://doi.org/10.1371/journal.pone.0170430.s002

(PDF)

Reference

  1. 1. Sugawara K, Honda K, Reien Y, Yokoi N, Seki C, Takahashi H, et al. (2016) A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agen. PLoS ONE 11(10): e0164785. pmid:27764176

Citation: The PLOS ONE Staff (2017) Correction: A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent. PLoS ONE 12(1): e0170430. https://doi.org/10.1371/journal.pone.0170430

Published: January 12, 2017

Copyright: © 2017 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.